About Shreenamo Biotech
Shreenamo Biotech is a Healthcare company. Biopharmaceutical manufacturing and supply of formulations and APIs for affordable medicines. The company has 1 employees. Its Indian entity Shreenamo Biotech Private Limited reported revenue of ₹4.13 Cr. Shreenamo Biotech offers products and services including Formulations and APIs. Its focus areas include Biopharmaceuticals, Drug Manufacturing, Formulations and APIs and Pharmaceuticals.
Company details
Shreenamo Biotech is recognized as a global biopharmaceutical company that is driven by the belief that affordable quality medicines should be accessible to everyone worldwide. It is headquartered in Delhi with manufacturing facilities situated in Haridwar, Uttarakhand, where state-of-the-art capabilities for formulations and APIs are maintained. Values such as quality compliance, employee safety, transparency, and respect are upheld, ensuring products are created with trust and ethical practices. The company is targeted to lead in speciality and generic therapeutics, with a commitment to responsible corporate citizenship and evolving processes.
- Employees 1
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website shreenamo.com
- Social X Instagram
- Legal Name Shreenamo Biotech Private Limited
- Date of Incorporation 09 May, 2019
- Jurisdiction New Delhi, Delhi, India
- Indian entity revenue₹4.13 Cr
FY 2025 · +9% YoY
- Indian entity net loss-₹9.1 Lakh
FY 2025 · -2% margin
- Indian entity EBITDA₹49.4 Lakh
FY 2025 · 12% margin
- Employee Count1
Associated legal entities of Shreenamo Biotech
Shreenamo Biotech operates through Shreenamo Biotech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Shreenamo Biotech Private Limited CIN U24304DL2019PTC349852 | Active | 09 May 2019 | New Delhi, Delhi | ₹4.1 Cr | 2 | View details |
Products & Services of Shreenamo Biotech
Shreenamo Biotech offers a comprehensive portfolio of products and services, including Formulations and APIs.
Formulations are manufactured across the pharmaceutical value chain for various therapeutic uses.
APIs are produced to support the creation of affordable quality medicines in the biopharmaceutical industry.
Board of directors of Shreenamo Biotech Private Limited (Shreenamo Biotech)
Shreenamo Biotech Private Limited is the primary company behind Shreenamo Biotech. The board of Shreenamo Biotech Private Limited currently have 2 directors; the longest-serving is Tarun Kumar Dawar, appointed in 2019.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Tarun Kumar Dawar DIN 01021151 | Director | 09 May 2019 | 7 yrs 5 mo | Shreenamo Biotech Private Limited |
| Satya Dawar DIN 08448078 | Director | 09 May 2019 | 7 yrs 5 mo | Shreenamo Biotech Private Limited |
Financials of Shreenamo Biotech
Figures of Shreenamo Biotech Private Limited, the primary company behind Shreenamo Biotech, for FY 2025. Revenue was ₹4.13 Cr (+9% year on year). Net loss was -₹9.1 Lakh (-2% margin). EBITDA was ₹49.4 Lakh (12% margin).
- ₹4.13 CrRevenue · FY 2025 · +9% YoY
- -₹9.1 LakhNet loss · -2% margin
- ₹49.4 LakhEBITDA · 12% margin
- ₹50 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Shreenamo Biotech Private Limited are on its company page.
Detailed financial statements for Shreenamo Biotech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Shreenamo Biotech
Shreenamo Biotech has 1 employees.
The primary company behind Shreenamo Biotech, Shreenamo Biotech Private Limited, reported revenue of ₹4.13 Cr for FY 2025, up 9% year on year.
Shreenamo Biotech is recognized as a global biopharmaceutical company that is driven by the belief that affordable quality medicines should be accessible to everyone worldwide. It is headquartered in Delhi with manufacturing facilities situated in Haridwar, Uttarakhand, where state-of-the-art capabilities for formulations and APIs are maintained. Values such as quality compliance, employee safety, transparency, and respect are upheld, ensuring products are created with trust and ethical practices. The company is targeted to lead in speciality and generic therapeutics, with a commitment to responsible corporate citizenship and evolving processes.
Shreenamo Biotech offers Formulations and APIs.
Shreenamo Biotech operates through Shreenamo Biotech Private Limited.
The legal entities of Shreenamo Biotech currently have 2 directors, including Tarun Kumar Dawar, Satya Dawar.